AB
NVCR icon

Amalgamated Bank’s NovoCure NVCR Stock Holding History

Amalgamated Bank’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,192
Closed -$41K – 2429
2025
Q4 		$41K Sell
3,192
-537
-14% -$6.89K ﹤0.01% 1876
2025
Q3 		$48K Hold
3,729
– – ﹤0.01% 1850
2025
Q2 		$66K Hold
3,729
– – ﹤0.01% 1773
2025
Q1 		$66K Buy
3,729
+13
+0.3% +$295 ﹤0.01% 1748
2024
Q4 		$111K Hold
3,716
– – ﹤0.01% 1684
2024
Q3 		$58K Hold
3,716
– – ﹤0.01% 1805
2024
Q2 		$64K Sell
3,716
-3,173
-46% -$55.8K ﹤0.01% 1805
2024
Q1 		$108K Sell
6,889
-14,174
-67% -$208K ﹤0.01% 1712
2023
Q4 		$314K Sell
21,063
-2,784
-12% -$37.3K ﹤0.01% 1629
2023
Q3 		$385K Buy
23,847
+1,072
+5% +$30.9K ﹤0.01% 1539
2023
Q2 		$945K Buy
22,775
+1,122
+5% +$69.7K 0.01% 1147
2023
Q1 		$1.3M Sell
21,653
-2,136
-9% -$171K 0.01% 1015
2022
Q4 		$1.75M Buy
23,789
+155
+0.7% +$11.7K 0.02% 947
2022
Q3 		$1.8M Buy
23,634
+398
+2% +$31K 0.02% 886
2022
Q2 		$1.61M Buy
23,236
+11,679
+101% +$880K 0.02% 944
2022
Q1 		$957K Buy
+11,557
New +$851K 0.01% 1220
2020
Q4 		– Sell
-20,102
Closed -$2.24M – 1595
2020
Q3 		$2.24M Sell
20,102
-513
-2% -$41K 0.1% 165
2020
Q2 		$1.22M Buy
20,615
+5,262
+34% +$346K 0.06% 338
2020
Q1 		$1.03M Sell
15,353
-511
-3% -$40.4K 0.03% 610
2019
Q4 		$1.34M Buy
15,864
+863
+6% +$69.7K 0.02% 684
2019
Q3 		$1.12M Sell
15,001
-190
-1% -$15.2K 0.02% 701
2019
Q2 		$961K Buy
15,191
+4,037
+36% +$205K 0.02% 770
2019
Q1 		$537K Buy
11,154
+450
+4% +$21.7K 0.01% 966
2018
Q4 		$358K Buy
10,704
+6,394
+148% +$234K 0.01% 1087
2018
Q3 		$226K Sell
4,310
-6,648
-61% -$265K 0.01% 1260
2018
Q2 		$343K Buy
+10,958
New +$305K 0.01% 1236

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Amalgamated Bank's NVCR Position: Q1 2026 in Review

Amalgamated Bank sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 3,192 shares — an estimated $41K sold.

Amalgamated Bank first reported a position in NVCR in Q2 2018 and held it in 26 quarters. The position peaked at $2.24M in Q3 2020. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Amalgamated Bank reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 3,192 NovoCure shares in Q1 2026, an estimated $41K.
  • Amalgamated Bank first reported a position in NovoCure in Q2 2018 and held it in 26 quarters.
  • Amalgamated Bank's NovoCure position peaked at $2.24M in Q3 2020.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.